Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Preface
Volume: 23 Issue: 1
Author(s): Emilio Jirillo
Affiliation:
Export Options
About this article
Cite this article as:
Jirillo Emilio, Preface, Endocrine, Metabolic & Immune Disorders - Drug Targets 2023; 23 (1) . https://dx.doi.org/10.2174/187153032301221123152701
DOI https://dx.doi.org/10.2174/187153032301221123152701 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |
12
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Purification and Characterization of a Novel Rhamnose/Fucose-Specific Lectin from the Hemolymph of Oak Tasar (Antheraea proylei J.) Silkworm
Protein & Peptide Letters Remote Preconditioning- Endocrine Factors in Organ Protection Against Ischemic Injury
Endocrine, Metabolic & Immune Disorders - Drug Targets Anti-Angiogenic Therapy: Strategies to Develop Potent VEGFR-2 Tyrosine Kinase Inhibitors and Future Prospect
Current Medicinal Chemistry HIV-1 Integrase: A Target for New AIDS Chemotherapeutics
Current Topics in Medicinal Chemistry First Discovery of Tylophora Alkaloids as HIV Inhibitors
Letters in Drug Design & Discovery The Effects of Sarcopenia on Muscles with Different Recruitment Patterns and Myofiber Profiles
Current Aging Science Spatial Interpolators for Intra-Frame Resampling of SAR Videos: A Comparative Study Using Real-Time HD, Medical and Radar Data
Current Signal Transduction Therapy Repurposing FDA-approved Drugs Targeting SARS-CoV2 3CL<sup>pro</sup>: A Study by Applying Virtual Screening, Molecular Dynamics, MM-PBSA Calculations and Covalent Docking
Letters in Drug Design & Discovery Common Aspects of Boronic Acids and Chalcogen Chemistry
Current Organic Chemistry Heteromerization as a Mechanism Modulating the Affinity of the ACE2 Receptor to the Receptor Binding Domain of SARS-CoV-2 Spike Protein
Current Proteomics Insights from Pharmaceutical Biotechnology into Phenolic Biopharmaceuticals against COVID-19
Current Pharmaceutical Biotechnology Repurposing Ruxolitinib in Combating COVID-19: A Mini-review
New Emirates Medical Journal Protein Targeting Constructs in Alpha Therapy
Current Radiopharmaceuticals Metallic Nanoparticles: A New Frontier in the Fight Against Leishmaniasis
Current Medicinal Chemistry Recent Advances in the Development of Nonpeptide Somatostatin Receptor Ligands
Mini-Reviews in Medicinal Chemistry Synthesis, Biological Evaluation, in Silico Docking and Virtual ADME Studies of Novel Isatin Analogs as Promising Antimicrobial Agents
Anti-Infective Agents MEET THE GUEST EDITOR
Combinatorial Chemistry & High Throughput Screening Molecular Docking and 3D-QSAR Studies on Quinolone-based HDAC Inhibitors
Letters in Drug Design & Discovery Unwinding Link between Coronavirus and Diabetes Patient
Endocrine, Metabolic & Immune Disorders - Drug Targets Estrogen Activates Classical and Alternative Mechanisms to Orchestrate Neuroprotection
Current Neurovascular Research